N/A
N=35
Tear Collection in Adult Volunteers
Healthy Volunteers
Bottom Line
View on ClinicalTrials.gov: NCT01969162 ↗Enrolled (actual)
35
Serious AEs
0.0%
Results posted
Nov 2014
Primary outcome: Primary: Tear Lipid Composition Profile — 39.34; 0.76; 6.58; 1.48 pmole
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Tear Sample Collection (Procedure)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Allergan
- Primary completion
- Nov 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Tear Lipid Composition Profile |
39.34; 0.76; 6.58; 1.48; 0.74; 1.43 | — |
Summary
This exploratory study will collect tear samples from adult volunteers for determining and quantifying tear composition profiles. No investigational drug will be administered in this study.
Eligibility Criteria
Inclusion Criteria
-Adult volunteers without ocular disease.
Exclusion Criteria
- Systemic medications that could affect eye health taken within 1 month of enrollment
- Eye infection or inflammation in either eye 3 months prior to screening
- History of herpes in either eye
- Diagnosis of dry eye or meibomian gland dysfunction
- Diagnosis of glaucoma
- Allergic conjunctivitis
- Use of rigid contact lenses within 1 year of screening
- Use of soft contact lenses within 1 week of enrollment.
Data sourced from ClinicalTrials.gov (NCT01969162). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.